Tricyclic antidepressants induce apoptosis in human T lymphocytes

International Journal of Immunopharmacology

Volumn 19, Issue 11-12, 1998, Pages 645-654

  Xia, Zhenlei ^a   Karlsson, Håkan ^a   Depierre, Joseph W ^a   Nässberger, Lennart ^a  

^a Unit for Biochemical Toxicology   (Sweden)

Author keywords

Apoptosis; DNA fragments; Flow cytometry; T lymphocyte; Tricyclic antidepressants

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; IMIPRAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0345310030     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(97)00020-9     Document Type: Article

References (25)

1. Bortner C. D., Oldenburg N. B. E., Cidlowski J. A. Trends in Cell Biology. 5:1995;21-26.
2. Byum A. Scand. J. Clin. Lab. Invest. 97:1968;9-108.
3. Cohen J. J. Immunology Today. 4:1993;126-130.
4. Cohen J. J., Duke R. C. J. Immunol. 132:1984;38-42.
5. Cohen J. J., Duke R. C., Fadok V. A., Sellins K. S. Annu. Rev. Immunol. 10:1992;267-293.
6. Dolzhanskiy A., Bash R. S. J. Immunol. Methods. 180:1995;131-140.
7. Duke R. C., Chervenak R., Cohen J. J. Proc. Natl. Acad. Sci. U.S.A. 80:1983;6361-6365.
8. Gerschenson, L. E. and Rotello, R. J. (1992) Apoptosis: a different type of cell death. FASEB J. 6, 2450-2455.
9. Golstein P., Ojcius D. M., Young J. D. Immunol. Rev. 121:1991;29-65.
10. Gougeon M.-L., Montagnier L. Science. 260:1993;1269-1270.
11. Groux H., Torpier G., Monte D., Mouton Y., Capron A., Ameisen J. C. J. Exp. Med. 175:1992;331-340.
12. Hansson, A. L., Xia, Z., Berglund, M. C., Berstrand, A., DePierre, J. W. and Nässberger, L. (1997) Reduced cell survival and morphological alterations induced by three tricyclic antidepressants in human peripheral monocytes and lymphocytes and in cell lines from these cell types. Toxicol. in Vitro (in press).
13. Kerr J. F. R., Wyllie A. H., Currie A.R. Br. J. Cancer. 26:1972;239-257.
14. Kizaki H., Shimada H., Ohsaka F., Sakurada T. J. Immunol. 141:1988;1652-1657.
15. Korsmeyer S. J. Blood. 80:1992;879-886.
16. Kroemer G. Adv. Immunol. 58:1995;211-296.
17. Mårtensson U., Nässberger L. Toxicol. in Vitro. 7:1993;241-245.
18. Pette M., Gold R., Pette D. F., Hartung H.-P., Toyka K. V. Immunopharmacol. 30:1995;59-69.
19. Steinberg A. D. Sem. Immunol. 6:1994;55-69.
20. Tuosto L., Lundari E., Montani M.S. G., Piccollella E. Eur. J. Immunol. 24:1994;1061-1065.
21. Ueda N., Shah S. V. J. Lab. Clin. Med. 124:1994;169-177.
22. Watanabe-Fukunaga R., Brannan C. I., Copeland W. G., Jenkins N. A., Nagata S. Nature. 356:1992;314-317.
23. Wu J., Zhou T., He J., Mountz J. D. J. Exp. Med. 178:1993;461-468.
24. Xia Z., DePierre J. W., Nässberger L. Immunopharmacol. 34:1996;27-37.
25. Not available.